Veri MedTech Holdings, Inc. (VRHI) Post-Termination ISO Calculator

Calculator · free · no signup · VRHI

Left Veri MedTech Holdings, Inc. with vested ISOs? Most plans give you 90 days to exercise or forfeit. See your deadline, the AMT cost of exercising, and the share count that maximizes after-tax value.

Beta · invite-only · AlphaLatitude Inc. · Free Tools

Your grant

pre-IPO? leave blank — enter price + growth manually
3 yrs
10%
20%
5.0%

Tax inputs

Grant timeline

Recommended exercise quantity

Exercise all 10,000

With 10%/yr expected growth over the 3-yr hold, every share's expected after-tax gain exceeds its marginal AMT cost. Net value: $171,946 at horizon.

Net after-tax value vs. shares exercised

Each point is the expected after-tax NPV at your hold horizon if you exercise that many shares now and let the rest expire.

$0$43K$86K$129K$172K02,5005,0007,50010,000
Recommended (10,000)Full exercise (10,000)

Year-by-year tax breakdown

You pay the higher of Regular tax and Tentative AMT per jurisdiction, then subtract Credit recovered. The result is Net tax. Hover any number for the bracket-by-bracket breakdown.

110,000
20
30

Federal AMT credit

Earned

$134,654

Recovered

$29,764

Remaining

$104,890

The AMT credit only recovers in years where regular tax exceeds AMT — typically a year with no ISO exercise. It carries forward indefinitely (Form 8801) and applies in any future tax year where regular tax exceeds AMT.

Estimates only. Excludes disqualifying dispositions, NSOs, multi-state moves, and AMT preferences other than ISO bargain elements. Long-term capital gains tax assumes a qualifying disposition (ISO held ≥1 yr from exercise and ≥2 yr from grant); state LTCG follows ordinary brackets except where the state grants preferential treatment (HI, ND, SC, WI, AR, NM) or has a dedicated LTCG-only tax (WA). Assumes you are within the $100K ISO limit (any portion of an annual ISO grant whose FMV at grant exceeds $100K is treated as NSO from the start, §422(d)). State AMT figures are 2025 (next-year values published in late 2026). Not financial advice.

QSBS note. If your shares qualify (typically pre-IPO C-corp grants held 5+ years), a federal rule lets you exclude up to $10M of gain on a future sale from federal tax. That single rule shifts exercise-timing math more than AMT does. (This is §1202 “qualified small-business stock”.) Modeled in beta, not here.

You solved the exercise window. The beta plans what comes after it: the new shares, your remaining equity, hedges, and taxes in one multi-year plan.

Request beta access →

About Veri MedTech Holdings, Inc.

Veri MedTech Holdings, Inc. (VRHI) is a public Vertical SaaS company.

OTC; cannabis telehealth.

Equity grants at Veri MedTech Holdings, Inc. typically include incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs).

Veri Medtech Holdings (OTC: VRHI) operates Veriheal, a telehealth platform founded in 2017 by Joshua Green and Samuel Adetunji that connects patients with state-licensed physicians for medical marijuana card certifications across multiple U.S. states. The Denver-based company has processed over 400,000 patient approvals through a network of roughly 400 physicians and reported cumulative revenue exceeding $100 million since inception, per a May 2025 company announcement. Veri Medtech filed an S-1 with the SEC in November 2025 seeking a $15 million Nasdaq uplisting at $4 per share, disclosing a going-concern risk tied to working capital deficits.

Sources: renaissancecapital.com · globenewswire.com

Equity comp at Veri MedTech Holdings, Inc.

  • OTC Pink Sheet micro-cap (ticker VRHI) with a pending Nasdaq uplisting through a small follow-on offering. The equity plan permits both options and RSUs, though concrete grant terms are not publicly disclosed in detail. Liquidity is currently constrained by thin OTC trading volume rather than a vesting trigger.
  • RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.

Sources: sec.gov

Researched 2026-05-11.

OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Veri MedTech Holdings, Inc..

If you have left Veri MedTech Holdings, Inc. (VRHI) with vested incentive stock options (ISOs), most stock plans give you 90 days from your departure date to exercise or forfeit them. Exercising everything at once concentrates the AMT bargain element into a single tax year. This calculator computes your window deadline from your departure date, the alternative minimum tax (AMT) cost of a full exercise at the current trading price, and the partial-exercise share count that maximizes expected after-tax value.

All Veri MedTech Holdings, Inc. tools → · Use the generic Post-Termination ISO Exercise Calculator for any company.

Veri MedTech Holdings, Inc. equity questions

I left Veri MedTech Holdings, Inc.. How long do I have to exercise my ISOs?
Most stock plans give you 90 days from your departure date to exercise vested incentive stock options (ISOs); unexercised options are forfeited when the window closes. Tax law is slightly wider: ISO treatment requires you to have been an employee within 3 months of exercise (Internal Revenue Code Section 422(a)(2)), so options exercised under an employer-extended window are taxed as non-qualified stock options (NSOs). Check your grant agreement for Veri MedTech Holdings, Inc.'s exact terms. The calculator above computes your deadline from your departure date, the alternative minimum tax (AMT) cost of exercising, and the share count that maximizes after-tax value.
Does Veri MedTech Holdings, Inc. grant ISOs, NSOs, or RSUs?
Equity compensation at Veri MedTech Holdings, Inc. typically takes the form of incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs). Incentive stock options can trigger the alternative minimum tax (AMT) when you exercise. Restricted stock units are taxed as ordinary income when they vest.
Do Veri MedTech Holdings, Inc. RSUs use double-trigger vesting?
No. Veri MedTech Holdings, Inc. restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyVertical SaaS peers

One piece of the puzzle.

OptionsAhoy plans your Veri MedTech Holdings, Inc. equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.

Request beta access